# BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: University of Illinois at Chicago · Condition: Breast Cancer

- Company: University of Illinois at Chicago
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06441890

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.